Security key
249845405
Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA)
CUSIP: 249845405
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common stock, par value $0.0001 per share
- Total 13F shares
- 508,154
- Total 13F value
- $297,499
- Share change
- -10,359
- SEC-reported price per share
- $0.58
- Number of holders
- 10
- Value change
- -$7,049
- Number of buys
- 8
- Number of sells
- 2
- Shares outstanding
- 4,233,387
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
10
Top holders
10
DRMA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Dermata Therapeutics, Inc. SEC filings
Dermata Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 249845405
Recent filing periods:
Ownership snapshot
Top reported holders of DRMA - Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PROEHL GERALD T
Disclosed value leader
Proehl Investment Venture...
Comparable rows
8/13
Latest evidence
31 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 13%
5 rows are not safely comparable across share classes.
13D/G row: PROEHL GERALD T
Showing 1-6 of 13 holder rows.
Quick read
PROEHL GERALD T leads the comparable SEC ownership view at 13%.
8 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PROEHL GERALD T's linked filing trail.
Comparable ownership
Top 5
PROEHL GERALD T
13%
ARMISTICE CAPITAL, LLC
10%
GEODE CAPITAL MANAGEMENT, LLC
0.48%
JONES FINANCIAL COMPANIES LLLP
0.28%
WELLS FARGO & COMPANY/MN
0.05%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PROEHL GERALD T |
13D/G
|
13%
|
$619,155
804,098 shares
|
$0 | 27 Mar 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
10%
|
$820,109
1,065,076 shares
|
+$607,264 | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.48%
|
$22,038
20,406 shares
|
— | 31 Mar 2025 |
| JONES FINANCIAL COMPANIES LLLP |
13F
Company
|
0.28%
|
$14,160
12,000 shares
|
— | 31 Mar 2025 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0.05%
|
$2,160
2,000 shares
|
— | 31 Mar 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.04%
|
$1,940
1,796 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
508,154
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
8
Q2 2025 holders
10
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend